Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova BioGenetics was a biotechnology company based in Atlanta, Georgia, that specialized in the development of advanced antimicrobial technologies. The company's core business centered on its proprietary BioShield technology, which utilized water-stabilized organosilane compounds to provide long-lasting antimicrobial protection on both skin and various surfaces. Publicly traded under the symbol NVBG, the company targeted applications in healthcare, industrial, and consumer markets to prevent the spread of bacteria, fungi, and algae. Its product portfolio included antimicrobial hand gels and surface treatments that were marketed for their durable, non-leaching properties. Although active in the late 1990s and early 2000s, the company eventually ceased operations, and its intellectual property was transitioned to other entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova BioGenetics.